Narrow-diameter Implants Replacing Maxillary Lateral Incisors
Five Year Outcomes at Two Narrow-diameter Implants to Replace Congenital Missing Maxillary Lateral Incisors
1 other identifier
observational
100
1 country
1
Brief Summary
To present the 5-year clinical, radiographic, and aesthetic outcomes in patients with congenitally missing lateral incisors (MLIs) rehabilitated with two narrow-diameter implants (NDIs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2024
CompletedFirst Submitted
Initial submission to the registry
July 8, 2024
CompletedFirst Posted
Study publicly available on registry
July 15, 2024
CompletedJuly 15, 2024
July 1, 2024
5.4 years
July 8, 2024
July 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Peri-implant marginal bone level changes
Changes in mm at the 1-year follow-up visit
1 year
Secondary Outcomes (3)
Implant Survival rate (%)
1-3-5 year
Aesthetic outcomes
1-3-5 year
PROMs
1-3-5 year
Study Arms (2)
Ø2.9mm (Test)
Test patients have received a 2.9 Ø dental implant
Ø3.3mm (Control)
Control patients have received a 3.3 Ø dental implant
Interventions
Surgery: Implant placement; Prothetic rehabilitation: single unit crown
Eligibility Criteria
Patients affected by congenital missing with uni- or bilateral maxillary lateral incisors (i.e. 12 and/or 22)
You may qualify if:
- Patients affected by congenital missing with uni- or bilateral maxillary lateral incisors (i.e. 12 and/or 22)
- Patients with systemic health or controlled medical conditions
- Patients arrested skeletal growth as documented by two body height measurements at least one year apart not indicating continuous growth (Jensen, 2019)
- Written Informed Consent
You may not qualify if:
- Patients contraindications to implant therapy (Hwang \& Wang, 2006, 2007) including
- Heavy smoking: \>20 cigarettes/day
- Poor oral hygiene
- Compromised compliance
- Periodontally compromised conditions
- Patients with MLI's with the canine situated in the MLI region
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bernlead
- Copenhagen University Hospital, Denmarkcollaborator
Study Sites (1)
University Hospital Copenhagen
Copenhagen, Denmark
Study Officials
- STUDY CHAIR
Simon Storgaard Jensen, Prof.
Copenhagen University Hospital, Copenhagen, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2024
First Posted
July 15, 2024
Study Start
August 1, 2016
Primary Completion
December 31, 2021
Study Completion
June 15, 2024
Last Updated
July 15, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share